Comparison of lovastatin (20 mg) and nicotinic acid (1.2 g) with either drug alone for type II hyperlipoproteinemia
- 15 July 1995
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 76 (3), 182-184
- https://doi.org/10.1016/s0002-9149(99)80056-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Lipoprotein Responses to Treatment With Lovastatin, Gemfibrozil, and Nicotinic Acid in Normolipidemic Patients With HypoalphalipoproteinemiaArchives of Internal Medicine, 1994
- Combination Drug Therapy for HypercholesterolemiaArchives of Internal Medicine, 1993
- The Efficacy of Intensive Dietary Therapy Alone or Combined with Lovastatin in Outpatients with HypercholesterolemiaNew England Journal of Medicine, 1993
- Raising HDL cholesterol with low-dose nicotinic acid and bezafibrate: preliminary experiencePublished by Oxford University Press (OUP) ,1993
- An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reductionThe American Journal of Cardiology, 1991
- Beneficial Effects of Colestipol-Niacin on Coronary AtherosclerosisPublished by American Medical Association (AMA) ,1990
- New Horizons in Combination Drug Therapy for HypercholesterolemiaJMIR AI, 1989
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac TransplantationNew England Journal of Medicine, 1988
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988